Drug class
Reversible acetylcholinesterase inhibitor; long-acting quaternary ammonium cholinergic agent
Mechanism of action
Inhibits acetylcholinesterase, increasing acetylcholine concentrations at the neuromuscular junction and improving neuromuscular transmission. Its quaternary ammonium structure limits central nervous system penetration.
General use cases
- Historically used for symptomatic treatment of myasthenia gravis; current availability and authorised status are limited and must be verified in the relevant jurisdiction
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
